Mutant KRAS in the initiation of pancreatic cancer
- PMID: 16169155
- DOI: 10.1016/j.bbcan.2005.08.003
Mutant KRAS in the initiation of pancreatic cancer
Abstract
Pancreatic ductal adenocarcinoma is the most common pancreatic neoplasm. There are approximately 33,000 new cases of pancreatic ductal adenocarcinoma annually in the United States with approximately the same number of deaths. Surgery represents the only opportunity for cure, but this is restricted to early stage pancreatic cancer. Pancreatic ductal adenocarcinoma evolves from a progressive cascade of cellular, morphological and architectural changes from normal ductal epithelium through preneoplastic lesions termed pancreatic intraepithelial neoplasia (PanIN). These PanIN lesions are in turn associated with somatic alterations in canonical oncogenes and tumor suppressor genes. Most notably, early PanIN lesions and almost all pancreatic ductal adenocarcinomas involve mutations in the K-ras oncogene. Thus, it is believed that activating K-ras mutations are critical for initiation of pancreatic ductal carcinogenesis. This has been proven through elegant genetically engineered mouse models in which a Cre-activated K-Ras(G12D) allele is knocked into the endogenous K-Ras locus and crossed with mice expressing Cre recombinase in pancreatic tissue. As a result, mechanistic insights are now possible into how K-Ras contributes to pancreatic ductal carcinogenesis, what cooperating events are required, and armed with this knowledge, new therapeutic approaches can be pursued and tested.
Similar articles
-
The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.Cancer Lett. 2013 Oct 1;339(1):135-43. doi: 10.1016/j.canlet.2013.07.010. Epub 2013 Jul 22. Cancer Lett. 2013. PMID: 23887057
-
A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.J Pathol. 2014 Oct;234(2):228-38. doi: 10.1002/path.4402. Epub 2014 Aug 4. J Pathol. 2014. PMID: 25042889
-
High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters.Carcinogenesis. 1996 Feb;17(2):303-9. doi: 10.1093/carcin/17.2.303. Carcinogenesis. 1996. PMID: 8625455
-
Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.Semin Radiat Oncol. 2005 Oct;15(4):254-64. doi: 10.1016/j.semradonc.2005.04.001. Semin Radiat Oncol. 2005. PMID: 16183479 Review.
-
Molecular genetics of pancreatic intraepithelial neoplasia.J Hepatobiliary Pancreat Surg. 2007;14(3):224-32. doi: 10.1007/s00534-006-1166-5. Epub 2007 May 29. J Hepatobiliary Pancreat Surg. 2007. PMID: 17520196 Free PMC article. Review.
Cited by
-
Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer.J Clin Invest. 2009 Sep;119(9):2725-36. doi: 10.1172/JCI39542. Epub 2009 Aug 17. J Clin Invest. 2009. PMID: 19690385 Free PMC article.
-
CXCL12 and Its Isoforms: Different Roles in Pancreatic Cancer?J Oncol. 2019 Jun 2;2019:9681698. doi: 10.1155/2019/9681698. eCollection 2019. J Oncol. 2019. PMID: 31275385 Free PMC article. Review.
-
Analysis of the methylation of CpG islands in the CDO1, TAC1 and CHFR genes in pancreatic ductal cancer.Oncol Lett. 2020 Mar;19(3):2197-2204. doi: 10.3892/ol.2020.11340. Epub 2020 Jan 23. Oncol Lett. 2020. PMID: 32194717 Free PMC article.
-
Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses.Biochim Biophys Acta. 2008 Apr;1785(2):217-31. doi: 10.1016/j.bbcan.2008.02.001. Epub 2008 Feb 15. Biochim Biophys Acta. 2008. PMID: 18328829 Free PMC article. Review.
-
siRNA-Loaded Hydroxyapatite Nanoparticles for KRAS Gene Silencing in Anti-Pancreatic Cancer Therapy.Pharmaceutics. 2021 Sep 8;13(9):1428. doi: 10.3390/pharmaceutics13091428. Pharmaceutics. 2021. PMID: 34575504 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous